Institut de Neurosciences Cognitives et Intégratives d'Aquitaine (UMR5287)

Aquitaine Institute for Cognitive and Integrative Neuroscience



INCIA - UMR 5287- CNRS
Université de Bordeaux

Zone nord Bat 2 2ème étage
146, rue Léo Saignat
33076 Bordeaux cedex
France

Téléphone 05.57.57.15.51
Télécopie 05.56.90.14.21

Supervisory authorities

CNRS Ecole Pratique des Hautes Etudes Université de Bordeaux

Our partners

Neurocampus Unitéde Formation de Biologie

GDR

GDR Robotique GDR Mémoire GDR Multi-électrodes

Search




Home > News

Take a look and publish !

by Loïc Grattier - published on

Take a look and publish !

Serotonin Research: Crossing scales and boundaries
Neuropharmacology (IF: 4.4)
https://www.journals.elsevier.com/neuropharmacology/call-for-papers/special-issue-call-for-original-papers-serotonin-research
Deadline: September 6th (cela a été repoussé récemment ; pas de frais de publications)
This special Issue is organized by Giuseppe Di Giovanni and Philippe De Deurwaerdère. It concerns the neuropharmacology of the serotonergic system. If you have some interesting data, don’t hesitate!

IJMS (IF: 4.18)
Serotonin
https://www.mdpi.com/journal/ijms/special_issues/Serotonin
Deadline: September 30th (Be carefull... it is an open access: 1600 CHF upon invitation)
Another special issue dedicated to serotonin, not only in the central nervous system.

New GPCR Targets and Modulators to Treat CNS Disorders
Frontiers in Molecular Neurosciences
https://www.frontiersin.org/research-topics/10176/new-gpcr-targets-and-modulators-to-treat-cns-disorders
Deadline: November (Publications fees)
It is a special issue dedicated to GPCR. There is no particular restriction (molecular, integrative neurobiology…), except for the publication fees.

Frontiers in Pharmacology:}

5-HT2C receptors
https://www.frontiersin.org/research-topics/9793/contemporary-perspective-on-5-ht2c-receptor-function-and-its-pharmacological-targeting
Deadline: September 20th (Publications fees)

Who is still working on 5-HT2C receptors? This special issue collects articles on this receptor and its influence on CNS function. It is also a major target in the treatment of obesity, anxiety, depression, and drugs of abuse.

Non-dopaminergic system in Parkinson’s disease
Frontiers in Pharmacology:
https://www.frontiersin.org/research-topics/9072/non-dopaminergic-systems-in-parkinsons-disease
Deadline : July 20th, but i twill be postponed.
It is a special issue on systems other than dopaminergic ones in Parkinson’s disease. It includes specific proteins to other systems of neurotransmission.

(image: INSERM Grenoble, Marc Savasta)